Gevo (GEVO) Receives ‘Analyst’ Rating

Gevo (GEVO) : 2 analysts are covering Gevo (GEVO) and their average rating on the stock is 2, which is read as a Buy. 1 equity analysts believe that the stock has a bright future and the price doesnt capture all of its upside, hence they rate the stock as a Strong Buy. A Zacks Investment Research rank of 2, which recommends a Buy affirms that they expect a large upside in the stock from the current levels. A total of 1 brokerage firms believe that the stock is fairly valued, hence they advise a Hold on the stock.

Gevo (GEVO) : 2 investment research analysts covering Gevo (GEVO) have an average price target of $2.3 for the near short term. The highest target price given by the Brokerage Firm to the stock is $4 and the lowest target is $1 for the short term. Analysts expect the variance to be within $2.4 of the average price.


Gevo (NASDAQ:GEVO): The stock opened in the green at $0.4749 on Thursday, but the bulls found it difficult to push the prices higher. The stock reached a high of $0.4799 and a low of $0.465 for the day. The stock did not find buyers even at the lows and closed at $0.4662 recording a loss of -1.85%. 4,491,656 shares exchanged hands during the trading day. The stock had closed at $0.475 in the previous days trading.

Gevo, Inc. (Gevo) is a renewable chemicals and biofuels company. The Compnay is focused on the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The Company operates through two segments: the Gevo, Inc. and the Gevo Development/Agri-Energy. The Gevo, Inc. segment is responsible for all research and development activities related to the production of isobutanol, including the development of its biocatalysts, the production and sale of biojet fuel. The Gevo Development/Agri-Energy Segment is responsible for the operation of its Agri-Energy Facility and the production of ethanol, isobutanol and related products.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.